Document Detail


Isolated cleft in the posterior mitral valve leaflet: a congenital form of mitral regurgitation.
MedLine Citation:
PMID:  19911346     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Isolated congenital cleft of the posterior leaflet of the mitral valve is a rare cause of mitral regurgitation (MR). This study describes the clinical, echocardiographic, and intraoperative findings as well as treatment options. METHODS: Adults with an isolated cleft of the posterior mitral valve leaflet diagnosed by transthoracic echocardiography were evaluated with respect to clinical, echocardiographic, preoperative and intraoperative findings, and different surgical strategies. RESULTS: The prevalence of isolated cleft of the posterior mitral valve leaflet in all patients examined was 0.11% (n = 22 out of 19 320 evaluated echocardiograms); male gender was predominant (73%). Dyspnea on exertion was present in almost all patients with at least moderate regurgitation. The predominant localization of the cleft was within segment P2 (59%), followed by a cleft between P1/P2 (18%). An isolated cleft in segment P3 or segment P1 occurred twice in each segment (n = 2; 9%) and between P2/P3 once (n = 1; 5%). Regurgitation was severe in 50% (n = 11), moderate in 9% (n = 2), mild in 27% (n = 6), and only trivial in 14% (n = 3) of the patients. Surgical treatment involved reconstruction with ring annuloplasty in 45% (n = 10) and replacement in 4.5% (n = 1). A total of 11 patients (50%) with mostly mild or trivial mitral regurgitation were treated medically only. CONCLUSION: Two-dimensional high-resolution cross-sectional echocardiography allows the distinct diagnosis of a clefted posterior leaflet, whereas clinical presentation, electrocardiogram, chest x-ray, and angiography are failing to identify the correct etiology of MR in patients with isolated posterior leaflet cleft mitral valve (IPLCMV). Patients with moderate to severe MR were treated surgically with excellent outcome.
Authors:
Christoph?? A Wyss; Frank Enseleit; Bernd van der Loo; J??rg Gr??nenfelder; Erwin N Oechslin; Rolf Jenni
Related Documents :
15222286 - Several new considerations in mitral valve repair.
15725156 - Ischemic mitral valve repair: predictive significance of restrictive left ventricular d...
19935816 - Nephroptosis in a young woman with joint laxity.
15473476 - Balloon mitral valvotomy after surgical commissurotomy: clinical and hemodynamic result...
9914576 - A new clinical option for hormone replacement therapy in women with secondary amenorrhe...
7016626 - The treatment of urinary tract infections in out-patients a double-blind comparison bet...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  32     ISSN:  1932-8737     ISO Abbreviation:  Clin Cardiol     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-11-20     Completed Date:  2010-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  553-60     Citation Subset:  IM    
Affiliation:
Clinic for Cardiology, University Hospital, 8091 Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Cardiovascular Agents / therapeutic use
Databases as Topic
Echocardiography, Doppler, Color
Female
Heart Valve Prosthesis Implantation
Humans
Male
Middle Aged
Mitral Valve / abnormalities*,  surgery,  ultrasonography
Mitral Valve Insufficiency / congenital*,  therapy,  ultrasonography
Severity of Illness Index
Time Factors
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Infection Prevention Check-In and Infection Prevention Check-Out to Prevent Nosocomial Infections.
Next Document:  In situ Gelation of Supramolecular Hydrogel for Anti-Tumor Drug Delivery.